Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding
Others
Ratios

Applied Therapeutics (APLT) Shares Outstanding (Weighted Average) (2023 - 2024)

Historic Shares Outstanding (Weighted Average) for Applied Therapeutics (APLT) over the last 2 years, with Q4 2024 value amounting to $139.5 million.

  • Applied Therapeutics' Shares Outstanding (Weighted Average) rose 6563.07% to $139.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $139.5 million, marking a year-over-year increase of 6563.07%. This contributed to the annual value of $139.5 million for FY2024, which is 6563.07% up from last year.
  • Applied Therapeutics' Shares Outstanding (Weighted Average) amounted to $139.5 million in Q4 2024, which was up 6563.07% from $125.3 million recorded in Q1 2024.
  • In the past 5 years, Applied Therapeutics' Shares Outstanding (Weighted Average) registered a high of $139.5 million during Q4 2024, and its lowest value of $56.4 million during Q1 2023.